Market closed

Immatics/$IMTX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Immatics

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Ticker

$IMTX
Trading on

Industry

Biotechnology
Headquarters

Employees

572

Immatics Metrics

BasicAdvanced
$818M
Market cap
-
P/E ratio
-$0.63
EPS
0.74
Beta
-
Dividend rate
$818M
0.74
$13.77
$6.68
626K
3.978
3.835
3.45
4.189
-77.72%
-8.28%
-17.70%
5.54
1.85
1.85
-14.374
52.53%
-43.52%
59.47%
-26.01%

What the Analysts think about Immatics

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Immatics stock.

Immatics Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Immatics Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IMTX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Immatics stock?

Immatics (IMTX) has a market cap of $818M as of December 22, 2024.

What is the P/E ratio for Immatics stock?

The price to earnings (P/E) ratio for Immatics (IMTX) stock is 0 as of December 22, 2024.

Does Immatics stock pay dividends?

No, Immatics (IMTX) stock does not pay dividends to its shareholders as of December 22, 2024.

When is the next Immatics dividend payment date?

Immatics (IMTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Immatics?

Immatics (IMTX) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.